ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Business deals

Takeda sells Russian assets in $660m deal to cut Shire debt

Japanese drugmaker unloads noncore businesses to focus on Asia and other priorities

Researchers work at a Takeda Pharmaceutical lab in Fujisawa, near Tokyo. (Photo courtesy of Takeda)

TOKYO -- Takeda Pharmaceutical has agreed to sell businesses in Russia and surrounding countries to a German competitor for $660 million as Japan's largest drug maker looks to further reduce its debt load.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more